DaVita HealthCare (DVA) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Over the past month, shares of this kidney dialysis provider have returned -1.7%, compared to the Zacks S&P 500 composite's -4.2% change. During this period, the Zacks Medical - Outpatient and Home Healthcare industry, which DaVita HealthCare falls in, has lost 4.4%. The key question now is: Wh ...

Kidney care provider enters virtual power purchase agreement in Spain after reaching 100% renewable energy goal in its North American operations DENVER, April 22, 2024  /PRNewswire/ -- By 2025, DaVita (NYSE: DVA), a leading provider of kidney care services, expects to match 100% of its electricity use across its global operations with renewable energy purchases. DaVita has contracted with ACCIONA Energía on a virtual power purchase agreement (PPA) facilitating the development of clean energy projects in Spa ...

DaVita HealthCare (DVA) ended the recent trading session at $127.82, demonstrating a +1.36% swing from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily loss of 0.88%. Meanwhile, the Dow gained 0.56%, and the Nasdaq, a tech-heavy index, lost 2.05%.Prior to today's trading, shares of the kidney dialysis provider had lost 7.44% over the past month. This has lagged the Medical sector's loss of 6.4% and the S&P 500's loss of 2.57% in that time.The investment community w ...

DaVita HealthCare (DVA) closed at $126.11 in the latest trading session, marking a -1.2% move from the prior day. The stock fell short of the S&P 500, which registered a loss of 0.22% for the day. At the same time, the Dow added 0.06%, and the tech-heavy Nasdaq lost 0.52%.Coming into today, shares of the kidney dialysis provider had lost 8.03% in the past month. In that same time, the Medical sector lost 6.22%, while the S&P 500 lost 1.66%.Investors will be eagerly watching for the performance of DaVita Hea ...

DENVER, April 17, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 2, 2024, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows: Thursday, May 2, 2024Starting at 5:00 p.m. EDTWebcast can be accessed using this link Dial in number: 877-918-6 ...

Just this morning, the CPI data reported a notable and surprise increase in the rate of inflation. Although disinflationary pressure have been strong since early 2023, it seems those forces have reversed, and policymakers may have to deal with the changing expectations.Because of this reversal in disinflation, the market expectations for a rate cut have fallen, and futures markets are now pricing in just two rate cuts starting in September, from three cuts starting in June. It is a pretty significant shift ...

DaVita Inc. (DVA) has been gaining from its business model. The optimism led by a solid fourth-quarter 2023 performance and the acquisition of dialysis centers are expected to contribute further. However, concerns regarding its dependence on commercial payers and macroeconomic challenges persist.Over the past year, this Zacks Rank #1 (Strong Buy) stock has gained 57.8% compared with a 15.7% rise of the industry and 27.4% growth of the S&P 500.The renowned global comprehensive kidney care provider has a mark ...

DaVita HealthCare (DVA) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Shares of this kidney dialysis provider have returned -3.7% over the past month versus the Zacks S&P 500 composite's +1.8% change. The Zacks Medical - Outpatient and Home Healthcare industry, to which DaVita HealthCare belongs, has lost 0.8% over this period. Now the key question is: Where coul ...

DENVER, April 10, 2024 /PRNewswire/ -- DaVita Inc. today announced that its Board of Directors has appointed a new independent director, Dennis Pullin, to join the Board, effective April 10, 2024."We're pleased to welcome Dennis to DaVita's board," said Pamela Arway, independent chair of the DaVita Inc. Board of Directors. "Given his depth of experience within the healthcare system, we're excited about the perspective Dennis will bring to the Board and look forward to his positive impact on our future growt ...

DaVita HealthCare (DVA) ended the recent trading session at $133.73, demonstrating a +0.09% swing from the preceding day's closing price. The stock's change was more than the S&P 500's daily loss of 0.04%. On the other hand, the Dow registered a loss of 0.03%, and the technology-centric Nasdaq increased by 0.03%.Shares of the kidney dialysis provider have depreciated by 1.15% over the course of the past month, underperforming the Medical sector's loss of 0.6% and the S&P 500's gain of 2.57%.Market participa ...